Hendrik Coenraad Hemker

This inventor holds 11 USPTO granted patents and 1 published patent application and 7 EPO patents. Top assignees: Synapse B.v., University of Maastricht, Academisch Ziekenhuis Maastricht. Active years: 1993-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hendrik Coenraad Hemker. Retrieved from https://idiyas.com/inventor/hendrik-coenraad-hemker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 1)

% Patents Active = 81.8

EPO Patents = 7 (Patent Applications = 6)

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 45(Granted Patents)

Company Filing History:

University of Maastricht

patents

1 out of 28

Academisch Ziekenhuis Maastricht

patents

4. 1 out of 67

Baxter Aktiengesellschaft

patents

5. 1 out of 29

Baxter Diagnostics Inc.

patents

6. 1 out of 12

Baxter Innovations Gmbh

where one patent can have more than one assignee

Years Active: 1993-2016

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9428790 - Simultaneous measurement of thrombin generation and clot strength in plasma and whole blood (2016-08-30),

2. 9155756 - Method for the prevention and treatment of sepsis (2015-10-13),

3. 8916356 - Measuring thrombin activity in whole blood (2014-12-23),

4. 8828730 - Method and assembly for measuring thrombin generation in plasma (2014-09-09),

5. 8802386 - Diagnostic test for determining the concentration of transient proteolytic activity in composite biological media (2014-08-12),

6. 7557188 - Methods of treating blood coagulation disorders using a pharmaceutical preparation comprising vWF propeptide (2009-07-07),

7. 7005502 - Pharmaceutical preparation comprising vWF propeptide (2006-02-28),

8. 6740496 - Determination of biologically active forms of proteolytic enzymes (2004-05-25),

9. 6140062 - Method of determining the heparin content (2000-10-31),

10. 6100050 - Factor VIII:Ca chromogenic assay (2000-08-08),

11. 5266462 - Measurement of platelet activities (1993-11-30),

Title: The Innovations of Hendrik Coenraad Hemker

Introduction

Hendrik Coenraad Hemker is a notable inventor based in Maastricht, Netherlands. He has made significant contributions to the field of medical treatment, particularly in the areas of thrombin generation and sepsis. With a total of 11 patents to his name, Hemker's work has had a profound impact on medical science.

Latest Patents

Among his latest patents is a method for the simultaneous measurement of thrombin generation and clot strength in plasma and whole blood. This innovative method utilizes a detectable substrate that releases a moiety upon reaction with the targeted proteolytic enzyme. It also includes elements for measuring an increase in viscosity of clot strength. Another significant patent is a method for the prevention and treatment of sepsis. This invention provides a novel use of pentasaccharide-depleted heparin for the treatment or prevention of sepsis, systemic inflammatory response syndrome, severe sepsis, or septic shock.

Career Highlights

Throughout his career, Hemker has worked with various organizations, including Synapse B.V. and Universiteit Maastricht. His expertise and innovative approaches have positioned him as a leader in his field.

Collaborations

Hemker has collaborated with notable colleagues such as Suzette Lucette Beguin and Robert Wagenvoord. These partnerships have further enhanced his research and development efforts.

Conclusion

Hendrik Coenraad Hemker's contributions to medical science through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the field and improve patient outcomes.

Profile summary based on public USPTO records.